2022
DOI: 10.1136/bmjoq-2022-001886
|View full text |Cite
|
Sign up to set email alerts
|

Increasing anti-S antibody testing: a quality improvement initiative with evolving COVID-19 guidelines

Abstract: BackgroundCOVID-19 management guidelines are constantly evolving, making them difficult to implement practically. Ronapreve was a neutralising monoclonal antibody introduced into UK COVID-19 guidelines in 2021. It reduces mortality in seronegative patients infected with non-omicron variants. Antibody testing on admission is therefore vital in ensuring patients could be considered for Ronapreve as inpatients.Local problemWe found that on our COVID-19 ward, 31.4% of patients were not having anti-S tests despite … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 7 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?